The Many Faces of Tau

Cited by (900)

Items 701–800 of 900

1. Rational Modulation of Liquid–Liquid Phase Separation Offers Novel Ways to Combat Tauopathies
   Xingxing Zhang, Lihua Wang, Nixin Lin, Meng Ying Gao, Yongqi Huang · 2025 · International Journal of Molecular Sciences
2. Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy
   Nimrod Miller, Zhaofa Xu, Katharina A. Quinlan, Amy Ji, Jered V. McGivern, Zhihua Feng, Han Shi, Chien‐Ping Ko, Li‐Huei Tsai, Charles J. Heckman et al. · 2023 · Proceedings of the National Academy of Sciences
3. Trichloroacetic acid treatment as a tricky way for rapid purification of 1N/4R tau protein
   Kazem Asadollahi, Saharnaz Rafiee, Gholam Hossein Riazi, Shahriar Pooyan, Ali Afrasiabi · 2015 · Protein Expression and Purification
4. Reward motivation and cognitive flexibility in tau null-mutation mice
   Sara Oberrauch, Jeremy A. Metha, Maddison L. Brian, Samuel A. Barnes, Travis J. Featherby, Andrew John Lawrence, Daniël Hoyer, Carsten Murawski, Laura H. Jacobson · 2020 · Neurobiology of Aging
5. Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation
   Haiyang Zhong, Hongli Liu, Huanxiang Liu · 2023 · Current Medicinal Chemistry
6. Suspended microtubules demonstrate high sensitivity and low experimental variability in kinesin bead assay
   Mehmet Cagatay Tarhan, Yslam Orazov, Ryuji Yokokawa, Stanislav L. Karsten, Hiroyuki Fujita · 2013 · The Analyst
7. HACS1 signaling adaptor protein recognizes a motif in the paired immunoglobulin receptor B cytoplasmic domain
   Jamie J. Kwan, Sladjana Slavkovic, Michael J Piazza, Dingyan Wang, Thorsten Dieckmann, Philip E. Johnson, Xiao‐Yan Wen, Logan W. Donaldson · 2020 · Communications Biology
8. Prediction and verification of the AD-FTLD common pathomechanism based on dynamic molecular network analysis
   Meihua Jin, Xiaocen Jin, Hidenori Homma, Kyota Fujita, Hikari Tanaka, Shigeo Murayama, Hiroyasu Akatsu, Kazuhiko Tagawa, Hitoshi Okazawa · 2021 · Communications Biology
9. Structural adjustment and social protection in the Middle East and North Africa: food subsidies in Jordan
   Yusuke Kawamura · 2014 · Contemporary Arab Affairs
10. Tau Protein and β-Amyloid Associated with Neurodegeneration in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis (EAE), a Mouse Model of Multiple Sclerosis
    Grażyna Pyka‐Fościak, Ewa Jasek-Gajda, B. Wójcik, GRZEGORZ J. LIS, Jan A. Litwin · 2024 · Biomedicines
11. Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies
    Siddhant Tripathi, Yashika Sharma, Dileep Kumar · 2024 · Current Protein and Peptide Science
12. Big Tau: Structure, Evolutionary Divergence, and Emerging Roles in Cytoskeletal Dynamics and Tauopathies
    Itzhak Fischer, Peter W. Baas · 2026 · Cells
13. Salt Dependence Conformational Stability of the Dimeric SAM Domain of MAPKKK Ste11 from Budding Yeast: A Native-State H/D Exchange NMR Study
    Anirban Bhunia, Humaira Ilyas, Surajit Bhattacharjya · 2020 · Biochemistry
14. Protective Effect of Hydroxysafflor Yellow A against Chronic Mild Stress-induced Memory Impairments by Suppressing Tau Phosphorylation in Mice
    Ying Wang, Qiang Wang, Jun Chen, Lihe Yao, Ni Tang, Zhenxiu Jiang, Yu Luo · 2021 · Current Medical Science
15. Biomedical research brings mTBI biomarkers a step closer to the bedside – implementation in clinical practice
    Martina Martiníková, Róbert Ružiňák, Egon Kurča, Michael T. Grey, Štefan Sivák · 2023 · General Physiology and Biophysics
16. Mixtures of Intrinsically Disordered Neuronal Protein Tau and Anionic Liposomes Reveal Distinct Anionic Liposome-Tau Complexes Coexisting with Tau Liquid–Liquid Phase-Separated Coacervates
    Christine K. Tchounwou, Anjali J. Jobanputra, Dylan Lasher, Bretton J. Fletcher, Jorge Jacinto, Arjun Bhaduri, Rebecca L. Best, William S. Fisher, Kai K. Ewert, Youli Li et al. · 2024 · Langmuir
17. Electrophysiology-based screening identifies neuronal HtrA serine peptidase 2 (HTRA2) as a synaptic plasticity regulator participating in tauopathy
    Naizhen Zheng, Kun Li, Jing Cao, Zijie Wang, Liang Zhang, Zihao Zhao, Jiawei He, Yong Wang, Xiang Zhu, Yiqing Chen et al. · 2025 · Translational Psychiatry
18. Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration
    Jingyu Mu, Zengrui Zhang, Chao Jiang, Haoming Geng, Junguo Duan · 2025 · Journal of Ophthalmology
19. Conformation- and phosphorylation-dependent electron tunnelling across self-assembled monolayers of tau peptides
    Ali Akbar Ashkarran, A. Hosseini, R. Loloee, George L. Perry, Ki‐Bum Lee, Mikael Lund, Mohammad Reza Ejtehadi, Morteza Mahmoudi · 2021 · Journal of Colloid and Interface Science
20. Tauopathy
    Hao Chi, Tzu‐Kang Sang, Hui-Yun Chang · 2019 · IntechOpen eBooks
21. Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons
    Valentina Lacovich, Sonia L. Espíndola, Matías Alloatti, Victorio M. Pozo Devoto, Lucas Eneas Cromberg, Mária E. Čarná, Giancarlo Forte, Jean‐Marc Gallo, Luciana Bruno, Gorazd Bernard Stokin et al. · 2017 · Journal of Neuroscience
22. Prospects and Challenges for Alzheimer Therapeutics
    Michael S. Wolfe · 2016 · Elsevier eBooks
23. Grove Arctic Curves from Periodic Cluster Modular Transformations
    Terrence George · 2019 · International Mathematics Research Notices
24. Serum tau concentration after diving – an observational pilot study
    Anders Rosén, Nicklas Oscarsson, Andreas Kvarnström, Mikael Gennser, Göran Sandström, Kaj Blennow, Helen Seeman-Lodding, Henrik Zetterberg · 2019 · Diving and Hyperbaric Medicine Journal
25. Potential Therapeutic Strategies to Prevent the Progression of Alzheimer to Disease States
    Ester Aso, Isidró Ferrer · 2013 · InTech eBooks
26. Potential neuroprotective strategies against tauopathy
    Jeanna M. Wheeler, Chris R. Guthrie, Brian C. Kraemer · 2012 · Biochemical Society Transactions
27. Phonetic variation in Standard Scottish English: Rhotics in Dundee
    Thomas Jauriberry, Rudolph Sock, Albert Hamm · 2015
28. Molecular Interactions between Tau Protein and TIA1: Distinguishing Physiological Condensates from Pathological Fibrils
    Safwa T. Kizhakkeduth, Arshad Abdul Vahid, Muhammed Shafeek Oliyantakath Hassan, Anagha K. Parambil, Parul Jain, Vinesh Vijayan · 2024 · ACS Chemical Neuroscience
29. Salivary total tau: a clinically practical measure of tau neuropathology in Alzheimer’s disease
    Alison R. Bamford, Christopher Logan, Q B Do, Kelly Nguyen, Liv C. McMillan, Michael A. Yassa, William Rodman Shankle, Elizabeth A. Thomas · 2026 · Journal of Neurology
30. Harmine and its derivatives: A promising multi-target therapeutic avenue for Alzheimer’s disease
    Xue Shen, Xiaoyu Dong, Jianfei Nao · 2026 · Neuroscience
31. Tridimensional Structural Analysis of Tau Isoforms Generated by Intronic Retention
    Indalo Domene-Serrano, Raquel Cuadros, Félix Hernández, Jesús Ávila, Ismael Santa‐María · 2023 · Journal of Alzheimer s Disease Reports
32. Recent Advances in Mapping Protein Self-Assembly and Aggregation for Common Proteinopathies
    Shapla Bhattacharya, Damien Thompson · 2024 · Acta Physica Polonica A
33. Mechanistic insights into the molecular and cellular basis of Alzheimer's disease
    A Issa · 2024 · Elsevier eBooks
34. Advancements in diagnosing Post-concussion Syndrome: insights into epidemiology, pathophysiology, neuropathology, neuroimaging, and salivary biomarkers
    Ioannis Asterios Mavroudis, Foivos Petridis, Alin Stelian Ciobica, Fatima Zahra Kamal, Manuela Pădurariu, Dimitrios A. Kazis · 2025 · Acta Neurologica Belgica
35. Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments
    Indalo Domene-Serrano, Raquel Cuadros, Vega García‐Escudero, Francisco Vallejo-Bedia, Ismael Santa‐María, Laura Vallés‐Saiz, Félix Hernández, Jesús Ávila · 2025 · Biochemistry
36. Effects of interval exercise and diurnal variation on blood biomarkers for sport-related concussion: A crossover cohort study
    Linden C. Penner, Jason Tabor, Joel S. Burma, Heather C Godfrey, Jean-Michel F Galarneau, Jennifer Gradi Cooper, Mohammad Ghodsi, Cheryl Lea Wellington, Chantel Teresa Debert, Carolyn A. Emery et al. · 2025 · Journal of science and medicine in sport
37. Nutrient sensing receptor GPRC6A regulates mTORC1 signaling and Tau biology
    Chao Ma, Kelsey Campbell, Andrii Kovalenko, Junyan Li, Leslie A. Sandusky‐Beltran, Huimin Liang, Jerry B. Hunt, John Ivan T. Calahatian, Mani Kallupurackal, Shalini Pandey et al. · 2025 · Neurobiology of Disease
38. Pericytes and the Neurovascular Unit: The Critical Nexus of Alzheimer Disease Pathogenesis?
    Steven P. Cercy · 2021 · Exploratory Research and Hypothesis in Medicine
39. Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort
    Christian LoBue, Barbara Elena Stopschinski, Nil Saez-Calveras, Peter M. Douglas, Ryan M. Huebinger, C. Munro Cullum, John Hart, Mitzi M. Gonzales · 2023 · Journal of Alzheimer s Disease
40. Neuroregeneration: Disease Modeling and Therapeutic Strategies for Alzheimer’s and Parkinson’s Diseases
    Angel J. Santiago-Lopez, Candice M. Hovell, Hyunjung Lee, YongTae Kim · 2015 · Biosystems & biorobotics
41. Cytoskeletal Elements in Neurotoxicity*
    Sally J. Pyle, Kenneth R. Reuhl · 2010 · Elsevier eBooks
42. Glymphatic System
    Helene Benveniste, Maiken Nedergaard · 2015 · Springer eBooks
43. The Therapeutic Effects of Seven Lycopodium Compounds on Cell Models of Alzheimer’s Disease
    Qian Guo, Qinfeng Cai, Fang Huang, Zhen Cheng Wei, Jian‐Zhi Wang, Bin Zhang, Rong Liu, Yang Yang, Xiaochuan Wang, Honglian Li · 2022 · Journal of Alzheimer s Disease
44. Tau protein aggregation: A therapeutic target for neurodegenerative diseases
    Aryan Duggal, Drishti Mahindru, Kirti Baghel, Sanjana Mehrotra, Vijay Kumar Prajapati · 2025 · Advances in protein chemistry and structural biology
45. Drosophila wing is a high-throughput and versatile screening tool for Tau-mediated disease mechanisms and drug discovery
    Miguel Ramírez Moreno, Amber S. Cooper, Tianshun Lian, Jie Liu, Seyedehleila Abtahi, Efthimios M. C. Skoulakis, Lovesha Sivanantharajah, Douglas W. Allan, Amritpal K. Mudher · 2026 · Disease Models & Mechanisms
46. Mechanistic insights into the synaptic damage-repair and regeneration processes in neurodegenerative Alzheimer’s disease: phytochemicals as neuroprotective agents
    Bharti Yadav, Prabhakar Gangwar, Kirti Kumari, Anuradha Yadav, Rashmi Rao, Keshav Kumar, Harkomal Verma, Monisha Dhiman, Anil Kumar Mantha · 2026 · Frontiers in Synaptic Neuroscience
47. Candidate biomarkers and CSF profiles for alzheimer’s disease and CADASIL
    Abdalla Bowirrat, Bishara Bisharat, Nseir William, Omary Muhamad, Mustafa Yassin · 2015 · Journal of Alzheimer’s Disease & Parkinsonism
48. Neurochemical Aspects of Alzheimer Disease
    A. A. Farooqui · 2016 · Springer eBooks
49. Endocrine Receptors: The Potential Therapeutic Targets for Alzheimer’s
    Tabassum Zafar, Ab Qayoom Naik, Bashirulla Shaik · 2023 · Springer eBooks
50. Stem Cells Vs Exosomes: Promising Therapeutic Approach and Biomarkers Agent against Neurodegenerative Disorders
    Johra Khan, I. İrem Tatlı · 2023 · Springer eBooks
51. Development of a sensor to detect methylmercury toxicity
    Akio Sumioka, Fusako Usuki, Masatake Fujimura · 2024 · Scientific Reports
52. Effect of stress on neuronal cell: Morphological to molecular approach
    Ishita Bhardwaj, Sippy Singh, Atifa Haseeb Ansari, Swayam Prabha Rai, Durgesh Singh · 2025 · Progress in brain research
53. Biomarkers for Alzheimer’s Disease: Imagination or Reality-View and Review!
    Mustafa Yassin, Zaher Armaly, Bishara Bisharat, Abdalla Bowirrat · 2013 · Journal of Behavioral and Brain Science
54. Chemical Modulators of Protein Misfolding, Neurodegeneration and Tau
    Pierfausto Seneci · 2015 · Elsevier eBooks
55. Date seeds alleviate behavioural and neuronal complications of metabolic syndrome in rats
    Yosra Dallagi, Dalila Rahali, Morgane Perrotte, Houssem Dkhili, Asma Korsan, Michèle Véronique El May, Saloua El Fazâa, Charles Ramassamy, Nargès El Golli · 2020 · Archives of Physiology and Biochemistry
56. Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
    Bruno Vasconcelos, Matthew Bird, Ilie‐Cosmin Stancu, Dick Terwel, Ilse Dewachter · 2017 · Elsevier eBooks
57. The role of protein phosphatase 2A tau axis in traumatic brain injury therapy
    Maibouge Tanko Mahamane Salissou, Yacoubou Abdoul Razak Mahaman, Xiaochuan Wang, Rabiu Abdussalam Magaji · 2022 · Beni-Suef University Journal of Basic and Applied Sciences
58. Deliberate self-harm in the South West: Setting a research agenda
    Yvette Morey, Lynne C. Eagle, Julia Verne, Helen Cook · 2011 · ResearchOnline at James Cook University (James Cook University)
59. Multiple amyloid binding sites in Alzheimer brain and their interaction with synaptic and inflammatory mechanisms
    Ruiqing Ni · 2015 · Figshare
60. Designed Peptides that Control Protein Nanoassemblies
    Hiroshi Inaba, Kazunori Matsuura · 2023 · Supramolecular Nanotechnology
61. Tau-Centric Therapies for Treating Alzheimer’s Disease
    Shmma Quraishe, C.M. Cowan, Amritpal K. Mudher · 2017 · Elsevier eBooks
62. Quantification of Methylation and Phosphorylation Stoichiometry
    Christopher A. Ayoub, Khadijah I. Moore, Jeff Kuret · 2024 · Methods in molecular biology
63. Prion protein prevents the inhibition of large-conductance calcium-activated potassium channel by Tau peptide K18 oligomers
    Yevheniia Kravenska, Piotr Koprowski, Hanna Nieznańska, Krzysztof Nieznański · 2024 · Biochemical and Biophysical Research Communications
64. Effect of PHF-1 hyperphosphorylation on the seeding activity of C-terminal Tau fragments
    Léa El Hajjar, Emmanuelle Boll, François‐Xavier Cantrelle, Clarisse Bridot, Isabelle Landrieu, Caroline Smet‐Nocca · 2025 · Scientific Reports
65. Isoforms of Phosphorylated Tau as Potential Biomarkers for Alzheimer’s Disease: The Contribution of Mass Spectrometry-Based Proteomics
    Marco Agostini, Pietro Traldi, Mahmoud H. Hamdan · 2025 · NeuroSci
66. Brain Injury Biomarkers in Humans Undergoing General Anaesthesia and Noncerebral Surgery
    Richard Vithal, Ali El‐Merhi, Amar Chandan, Anna Kosovic, Helena Odenstedt Hergès, Henrik Zetterberg, Christina Biörserud, Miroslaw Staron, Jaquette Liljencrantz, Linda Block · 2025 · Acta Neurologica Scandinavica
67. The application of directly induced neurons into neurodegenerative disease modeling
    Keita Matsumoto, Sumihiro Maeda · 2025 · Neuroscience Research
68. Integrated network pharmacology, molecular docking and MD simulation unravel neuroprotective phytochemicals from aframomum melegueta targeting microglial neuroinflammation in Alzheimer’s disease
    Sameera Khan, Prinsa, Nargis Bano, Faaizah Fazal, Shakir Ahamad, Supriyo Saha, Nawab John Dar, Shahnawaz Ali Bhat · 2026 · Network Modeling Analysis in Health Informatics and Bioinformatics
69. Canine Cognitive Dysfunction and Alzheimer’s Disease: Pathophysiological Relationships and the Impact of Glymphatic System Impairment on Neurodegeneration
    Maurizio Dondi, Ezio Bianchi, Paolo Borghetti, Rosanna Di Lecce, Giacomo Gnudi, Chiara Guarnieri, Valentina Buffagni, Francesca Ravanetti, Roberta Saleri, Attilio Corradi · 2026 · Veterinary Sciences
70. Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease
    Joshua T. Skrehot, Dmitry Kurouski · 2026 · Protein Science
71. Spatial-temporal reasoning applications of computational intelligence in the game of Go and computer networks
    Tae Hyung Kim · 2012
72. Cellular Prion Protein and Cancers
    Wei Xin, Man‐Sun Sy, Chaoyang Li · 2012 · Springer eBooks
73. A stochastic approach to rhotic variation in Spanish codas
    Mark Gibson · 2015 · Loquens
74. Tau Phosphorylation as a Therapeutic Target in Alzheimer’s Disease
    Miguel Medina, Jesús Ávila · 2016 · Elsevier eBooks
75. Sensitive immunoassay testing platforms
    Maximo J Marin, Xander M.R. van Wijk · 2020 · Elsevier eBooks
76. Protein–Protein Interactions in Neurodegenerative Diseases
    Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, Nupur Nagar · 2023 · Springer eBooks
77. Perspective Chapter: Challenges in the Diagnosis of Post-Concussion Syndrome – Epidemiology, Pathophysiology, Neuropathology, Neuroimaging Biomarkers, and Salivary Biomarkers
    Ioannis Asterios Mavroudis, Foivos Petridis, Alin Stelian Ciobica, Fatima Zahra Kamal, Manuela Pădurariu · 2024 · IntechOpen eBooks
78. Autophagy in Alzheimer’s disease: A Cleaning Service Out-of-order?
    Sónia C. Correia, Paula Isabel Moreira, George L. Perry · 2015 · Current topics in neurotoxicity
79. Copper and Alzheimer Disease: The Good, the Bad and the Ugly
    Ya Hui Hung, Ashley Ian Bush, Robert A. Cherny · 2012 · Springer eBooks
80. Reduce the Risk of Dementia; Early Diagnosis of Alzheimer’s Disease
    Shweta Jakhmola, Hem Chandra Jha · 2018 · Advances in intelligent systems and computing
81. Antisense-Oligonukleotide I
    Claudia D. Wurster, Albert Christian Ludolph, Denise Lehmann, Heiko Graf · 2018 · Nervenheilkunde
82. Влияние бета-амилоидных пептидов и основного стресс-белка HSP70 на протеом клеток SH-SY5Y нейробластомы человека
    Alexander P. Rezvykh, М. М. Юринская, М. Г. Винокуров, George Sergeevich Krasnov, Vladimir A. Mitkevich, Alexander А. Makarov, Michael B. Evgen’ev, Olga G. Zatsepina · 2018 · Molecular Biology
83. Tau, Tangles and Tauopathies: Insights from Drosophila Disease Models
    Nisha Nisha, Pragati, Shweta Tandon, Aqsa Aqsa, Prerna Aggarwal, Surajit Sarkar · 2019 · Springer eBooks
84. Soluble 4R0N Tau Abrogates Endocytic Vesicular Dynamics
    Tharun Selvam Mahendran, Shwetha Suresh, Lakshmi Garimella, Ravi R. Manjithaya · 2020 · Frontiers in Aging Neuroscience
85. Glymphatic System
    Helene Benveniste, Maiken Nedergaard · 2022 · Springer eBooks
86. The aging synapse: Synaptic proteome changes in mouse models of aging
    Marlene J. Végh · 2012 · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
87. Drug therapies for Alzheimer's disease
    Emma Louise Cunningham, Anthony Peter Passmore · 2013 · British Journal of Mental Health Nursing
88. Traumatic Brain Injury and Neurodegenerative Disease
    Dawn McGuire · 2018 · Wiley eBooks
89. Overexpression of HIF-2α in Protected Regions of Alzheimer’s disease Resilient Cases
    Vivianne Mitri · 2020 · medRxiv
90. Iron Homeostasis and Neurodegeneration
    Robert R. Crichton · 2016 · Wiley eBooks
91. Tau-seed interactome analysis reveals distinct functional signatures in Alzheimer’s disease across model systems
    Pablo Martínez, Henika Patel, Yanwen You, Daniella Lopes, Armando Amaro, Nur Jury, Yuhao Min, Javier Redding‐Ochoa, Sayan Dutta, Jean‐Christophe Rochet et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
92. Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease
    Chimal-Juárez, Enrique, Patel, Henika, Jury-Garfe, Nur, Dabin, Luke C., Vidal, Ruben, Kim, Jungsu, Lasagna-Reeves, Cristian A. · 2026 · bioRxiv
93. Pharmacodynamic Mechanisms of Tolfenamic Acid Induced SP1 Degradation Relative to Alzheimer's Disease Pathology
    Lina I. Adwan · 2013 · Digital Commons - URI (University of Rhode Island)
94. Interaction between Peptide Pheromone or Its Truncated Derivatives and Pheromone Receptor of the Fission Yeast Schizosaccharomyces pombe Examined by a Force Spectroscopy Study and a GFP Reporter Assay
    Sho Hidaka, Osamu Nikaido, Shoichi Kiyosaki, Atsushi Ikai, Toshiya Osada · 2013 · Journal of Surface Engineered Materials and Advanced Technology
95. Las percepciones de amenazas y de seguridad entre Europa y el mundo árabe
    Martín Jerch, Alejandro V. Lorca Corróns · 2011 · Estudios Internacionales
96. depression in the hippocampus Microtubule-associated protein tau is essential for long-term
    Eunjoon Kim, Graham L. Collingridge, Akihiko Takashima, Kwangwook Cho Christopher Brown, Tsutomu Hashikawa, Miyuki Murayama, Heon Seok, Ioannis Sotiropoulos, Tetsuya Kimura, Daniel J. Whitcomb et al. · 2013
97. Tau Pathology: A Selected View on the Current Status
    Illana Gozes · 2012 · Advances in predictive, preventive and personalised medicine
98. CD64-mediated specific elimination of M1-polarized macrophages : implications for therapeutic intervention in chronic inflammatory diseases
    Dmitrij Hristodorov, Universitätsprofessor Dr. Rainer Fischer · 2013 · RWTH Publications (RWTH Aachen)
99. The Tau of Myelin Basic Protein (MBP): Biophysical Studies of Microtubule Assembly by MBP
    Agata Zienowicz · 2014 · The Atrium (University of Guelph)
100. Dysregulation of neuronal calcium signaling impairs axonal transport independent of tau in a model of Alzheimer's disease
     Kathlyn J. Gan · 2014 · Summit (Simon Fraser University)